エフェロサイトーシス促進薬による慢性炎症性疾患治療法の開発

• Project/Area Number: 25K22562
• Research Category: Grant-in-Aid for Challenging Research (Exploratory)
• Allocation Type: Multi-year Fund
• Review Section: Medium-sized Section 49:Pathology, infection/immunology, and related fields
• Research Institution: Tokai University
• Principal Investigator: 八幡 崇 東海大学, 医学部, 教授 (10398753)
• Project Period (FY): 2025-06-27 – 2027-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000); Fiscal Year 2026: ¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000); Fiscal Year 2025: ¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)